** = Publications listed in SCI/SSCI/Pubmed
** Metzner, T; Leitner, DR; Dimsity, G; Gunzer, F; Opriessnig, P; Mellitzer, K; Beck, A; Sourij, H; Stojakovic, T; Deutschmann, H; März, W; Landmesser, U; Brodmann, M; Reishofer, G; Scharnagl, H; Toplak, H; Silbernagel, G
Short-Term Treatment with Alirocumab, Flow-Dependent Dilatation of the Brachial Artery and Use of Magnetic Resonance Diffusion Tensor Imaging to Evaluate Vascular Structure: An Exploratory Pilot Study.
Biomedicines. 2022; 10(1):
Doi: 10.3390/biomedicines10010152
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Metzner, T; Leitner, DR; Dimsity, G; Gunzer, F; Opriessnig, P; Mellitzer, K; Beck, A; Sourij, H; Stojakovic, T; Deutschmann, H; Arz, WM; Landmesser, U; Brodmann, M; Reishofer, G; Scharnagl, H; Toplak, H; Silbernagel, G
SHORT-TERM EFFECTS OF INTENSIVE LDL-CHOLESTEROL LOWERING WITH ALIROCUMAB ON VASCULAR STRUCTURE AND FUNCTION
ATHEROSCLEROSIS. 2021; 331: E228-E228.
[Poster]
Web of Science
** Tripolt, NJ; Aberer, F; Riedl, R; Url, J; Dimsity, G; Meinitzer, A; Stojakovic, T; Aziz, F; Hödl, R; Brachtl, G; Strunk, D; Brodmann, M; Hafner, F; Sourij, H
Effects of linagliptin on endothelial function and postprandial lipids in coronary artery disease patients with early diabetes: a randomized, placebo-controlled, double-blind trial.
Cardiovasc Diabetol. 2018; 17(1):71-71
Doi: 10.1186/s12933-018-0716-x
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Aberer, F; Tripolt, N; Riedl, R; Hutz, B; Url, J; Brodmann, M; Meinitzer, A; Stojakovic, T; Dimsity, G; Hodl, R; Hafner, F; Sourij, H
The Effect of Linagliptin on the Endothelial Function and Arginine Bioavailability Ratio in CHD Patients with Early Type 2 Diabetes Mellitus - A Randomized Controlled Trial.
WIEN KLIN WOCHENSCHR. 2017; 129: 162-162.
[Oral Communication]
Web of Science
** Tripolt, NJ; Aberer, F; Riedl, R; Hutz, B; Url, J; Dimsity, G; Meinitzer, A; Stojakovic, T; Hödl, R; Brodmann, M; Hafner, F; Sourij, H
The effects of linagliptin on endothelial function and global arginine bioavailability ratio in coronary artery disease patients with early diabetes: study protocol for a randomized controlled trial.
Trials. 2016; 17(1):495-495
Doi: 10.1186/s13063-016-1627-3
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Dorr, A; Dimsity, G; Skerget, G; Seinost, G; Pilger, E; Brodmann, M
Is there seasonal differences in the flow-mediated vasodilatation of the brachial artery in patients with primary and secondary Raynaud phenomenon.
MED KLIN. 101: A8-A9.-112. Kongress der deutschen Gesellschaft für Innere Medizin; April 22-26, 2006; Wiesbaden, Deutschland.
[Poster]
Web of Science